Skip to main content

Smallpox News

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX (tecovirimat)

NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) – SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the ...

FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox

DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) – Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Viral Infection